Methotrexate-induced pneumonitis

H. Dirk Sostman, Richard A. Matthay, Charles E. Putman, G. J.Walker Smith

Research output: Contribution to journalArticlepeer-review

223 Scopus citations


Methotrexate pneumonitis is characterized by dyspnea, non productive cough, fever and hypoxemia. Peripheral eosinophilia is frequently present. Early in the disease the chest radiograph demonstrates interstitial infiltrates after progressing to an alveolar filling pattern which clears rapidly in most cases. However, radiographic and pulmonary function test abnormalities may persist chronically after methotrexate is discontinued. The histopathologic features include interstitial and alveolar infiltrates of round cells. Granulomas and interstitial fibrosis have been noted in some cases. The precise manner in which methotrexate induces pulmonary disease is not known but both allergic and cytotoxic etiologies have been suggested. Corticosteroid therapy favors recovery, although 11% of cases reported in the literature of cases have died in the acute phase, indicating that methotrexate therapy may lead to severe complications (95 references).

Original languageEnglish (US)
Pages (from-to)371-388
Number of pages18
JournalMedicine (United States)
Issue number5
StatePublished - Sep 1976

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Methotrexate-induced pneumonitis'. Together they form a unique fingerprint.

Cite this